drugset / Trial / NCT06962657

Mitigating Toxic Impact: The Role of Coenzyme Q10 in Post-Exposure Protection

NCT06962657

Phase 2 Not yet recruiting 20 enrolled University of California, San Diego
RandomizedCrossoverQuadruple-blindTreatment

Summary

This research study is being conducted to see if coenzyme Q10 (a nutritional supplement) might help to prevent and/or alleviate symptoms and health consequences and help to improve quality of life and physical function in residents affected by the February 2023 East Palestine, Ohio train derailment. This is a pilot study that is not powered to achieve benefit but seek to examine effect size and variance to aid in power calculations for a potential future better powered study.

Timeline

Start
2026-05-15
Primary completion
2028-10-01
Completion
2028-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Coenzyme Q10 Other / unclassified 100 mg Oral

Indications

No indication recorded.